Kenalog

Triamcinolone acetonide, the active ingredient in Kenalog, is a corticosteroid presented as a sterile solution for intravenous use. It provides anti‑inflammatory and immunosuppressive effects and is used in various inflammatory and allergic conditions in adults and children.

GNH USA supplies Kenalog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kenalog is a glucocorticoid used to manage conditions driven by excessive inflammation or allergic responses.

- Severe allergic reactions: rapid reduction of systemic inflammation and symptom relief. - Acute asthma exacerbations: improves airway patency and reduces bronchial swelling. - Rheumatoid arthritis flares: decreases joint inflammation and pain. - Severe dermatologic conditions (e.g., eczema, psoriasis): suppresses skin inflammation and pruritus.

Kenalog may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Insomnia and mood changes: including anxiety or euphoria. - Increased appetite and weight gain. - Fluid retention leading to peripheral edema.

Serious or Rare Side Effects: - Adrenal suppression: risk of insufficiency after abrupt discontinuation. - Severe infections: heightened susceptibility to bacterial, viral, or fungal pathogens. - Osteonecrosis of the jaw or long bones. - Ocular complications such as cataracts or glaucoma. - Anaphylactic reactions: rare but potentially life‑threatening.

Before initiating Kenalog therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess infection risk: avoid use in active systemic infections. - Monitor blood glucose: adjust antidiabetic therapy as needed. - Check blood pressure: watch for hypertension or fluid overload. - Use the lowest effective dose: limit duration to reduce systemic exposure. - Taper after prolonged therapy: prevent adrenal crisis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Kenalog can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid levels. - Live vaccines: risk of uncontrolled infection. - Anticoagulants (e.g., warfarin): enhanced bleeding risk. - NSAIDs: increased gastrointestinal ulceration.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate electrolyte disturbances. - Antidiabetic agents: may require dose adjustment due to hyperglycemia. - ACE inhibitors or ARBs: potential for additive blood pressure effects. - Non‑live vaccines: monitor immune response.